Find Resources
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Peer Review Study
This report discusses a series of interventions that Genesis HealthCare, one of the largest long-term care providers in the US, implemented in response to lower COVID-19 vaccination uptake among Hispanic and black Genesis staff members. The organization’s Vaccine Acceptance Steering Committee worked with their DEI Committee to develop a more comprehensive education strategy to improve vaccination acceptance among BIPOC staff that included offering vaccine information sessions at all times of the day and the night, inviting staff family members and friends to participate in these sessions, creating more multilingual educational materials, and featuring DEI Committee members in the organization’s social media campaigns. At the end of the one month intervention, statistically significant improvements in the likelihood of being vaccinated compared with white staff members increased for black and Hispanic employees.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study
According to recent data from the Centers for Disease Control and Prevention (CDC), the percentage of individuals reporting Long COVID symptoms has decreased from 19% in June 2022 to 11% in January 2023 among those who have had COVID-19. While this decline is notable, 15% of all US adults have reported experiencing Long COVID symptoms at some point, with 6% currently affected. Long COVID continues to pose challenges, including limitations in daily activities for 79% of those affected and potential long-term disabilities. Efforts to address Long COVID include research initiatives and public health actions, but its full impact and the reasons behind the decline in reported cases remain subjects of ongoing study and concern.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
White Paper/Brief
This article explores the challenges of communicating public health guidance during a pandemic, focusing on the example of mask recommendations in the early stages of the COVID-19 pandemic in the United States. It underscores the ethical dilemmas faced by public health officials in balancing transparency with evolving scientific knowledge and resource shortages. Initially, there was hesitation in recommending masks for the general public due to concerns about mask shortages, leading to mixed messaging. As evidence supporting mask effectiveness grew, guidance shifted to advocating universal mask use, contributing to public confusion and mistrust. The article underscores two key ethical principles: the precautionary principle, advocating for protective action in uncertain situations, and harm reduction, emphasizing minimizing harm when complete risk elimination is unfeasible. It also highlights the importance of transparent communication but acknowledges that excessive transparency can sometimes cause confusion and mistrust. To enhance public health communication during uncertainty and resource scarcity, the article recommends utilizing trusted messengers, structuring uncertainty, acknowledging the role of values in recommendations, and recognizing emotional responses to risk information.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
White Paper/Brief
The 2019 call for papers on “Taboos in Health Communication: Stigma, Silence, and Voice” coincided with the emergence of COVID-19, which drastically transformed the world. This pandemic, with over 235 million cases and nearly 5 million deaths by October 2021, not only had severe health consequences but also led to economic and social crises, including increased domestic violence and mental health issues. It pushed health communication and public relations to the forefront of crisis management, overshadowing other health concerns. This shift highlighted the importance of addressing taboos, stigmas, and silences, particularly in areas like mental and reproductive health, maternal health, and vaccination efforts. The special issue explores how public relations and health communication influence public discourse and societal norms, challenging established assumptions and power dynamics in a COVID-19-dominated world. It acknowledges the historically limited connection between public health and public relations and calls for addressing cultural taboos and stigmas. The issue advocates for applying critical theory in health communication and promoting an interdisciplinary approach to address these challenges, with the ultimate goal of integrating public relations insights into broader socio-cultural, political, and economic discussions in the post-pandemic era.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study
The study conducted by the Centers for Disease Control and Prevention (CDC) and Federal Emergency Management Agency (FEMA) assessed high-throughput COVID-19 vaccination sites in the United States, including Puerto Rico, to identify promising practices for their implementation. Through site observations and staff interviews, they conducted 134 assessments in multiple states, highlighting practices related to health equity, partnerships, site design, visual communication, quick response codes, and risk management. These findings can aid in the planning and execution of future vaccination operations for COVID-19, influenza, and other vaccine-preventable diseases, offering valuable insights to vaccination planners and providers for strengthening their site plans and implementation strategies.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
White Paper/Brief
The article highlights the lessons learned from the COVID-19 pandemic and their influence on preparations for future public health emergencies. While the federal Public Health Emergency for COVID-19 is set to end in May 2023, the FDA emphasizes the continued importance of COVID-19 vaccines and treatments. Addressing misinformation and strengthening supply chain resilience are key priorities, and the FDA is developing more efficient inspection planning systems. Modernizing FDA authorities and maintaining a commitment to planning for the future are also emphasized to enhance national security and public health preparedness.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
White Paper/Brief
Using a grant from the National Science Foundation, Predictive Intelligence for Pandemic Prevention (PIPP) developed tools and systems to respond effectively to infectious disease pandemics. Recommendations from this work include avoiding reinvention of the wheel by centralizing and standardizing approaches to pandemic response planning, collaboration and information sharing among public health stakeholders, investing in high-performance computing and data management systems for public health, creating a national center for pandemic response, developing playbooks for fast-moving threats, and identifying sustainable and scalable solutions.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
White Paper/Brief
Director of the Health Equity Core at Harvard Medical School, Professor Sprague Martinez has organized a team of partners to identify the impact of long COVID on Black and Latinx communities in Massachusetts and barriers they experience in accessing treatment. The project is part of the Massachusetts Consortium on Pathogen Readiness, which aims to address the challenges of COVID-19 and future pandemics. The Health Equity Core focuses on understanding the impact of long COVID on diverse communities, increasing access to treatment and resources, and influencing relevant policies. The team includes partners from various institutions and will emphasize community engagement, data collection, dissemination, and policy advocacy efforts.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Peer Review Study
The article explores how long COVID is influenced by social determinants like poverty and structural inequalities such as racism. It emphasizes the role of primary care in providing and coordinating care for vulnerable patients. Policy measures like strengthening primary care and addressing barriers faced by vulnerable populations are recommended. High-quality data collection and addressing social determinants of health are also highlighted.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
White Paper/Brief
This article discusses strategies to promote equity in COVID-19 antiviral treatment. It highlights the disproportionate effect of the pandemic on marginalized groups and the need to address inequities in access to antiviral medications. The authors discuss barriers to equity, such as low awareness, limited access to healthcare, scarcity of therapeutics, and treatment prioritization. They propose strategies to overcome these barriers, including community-driven outreach campaigns, addressing healthcare costs for uninsured patients, transparent allocation of therapeutics, and monitoring data to ensure equity. The article emphasizes the importance of proactive and transparent approaches to promote health equity in COVID-19 treatment.